Federal Register / Vol. 72, No.
244 / Thursday, December 20, 2007 / Notices 72433
as of the date each member organization
implements riskless principal routing,
the member organization have in place
systems and controls that allow them to
easily match and tie the riskless
principal execution on the Exchange to
the underlying orders and that they be
able to provide this information to the
Exchange upon request.
2. Statutory Basis
The basis under the Act for this
proposed rule change is the requirement
under section 6(b)(5) 6 that an Exchange
have rules that are designed to promote
just and equitable principles of trade, to
remove impediments to and perfect the
mechanism of a free and open market
and a national market system, and, in
general, to protect investors and the
public interest.
B. Self-Regulatory Organization’s
Statement on Burden on Competition
The Exchange does not believe that
the proposed rule change will impose
any burden on competition that is not
necessary or appropriate in furtherance
of the purposes of the Act.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants, or Others
The Exchange has neither solicited
nor received written comments on the
proposed rule change.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
Because the proposed rule change: (i)
Does not significantly affect the
protection of investors or the public
interest; (ii) does not impose any
significant burden on competition; and
(iii) does not become operative for 30
days after the date of the filing, or such
shorter time as the Commission may
designate if consistent with the
protection of investors and the public
interest, the proposed rule change has
become effective pursuant to section
19(b)(3)(A) of the Act 7 and Rule 19b–
4(f)(6) thereunder.8
At any time within 60 days of the
filing of the proposed rule change, the
Commission may summarily abrogate
the rule change if it appears to the
6 15 U.S.C. 78f(b)(5).
7 15 U.S.C. 78s(b)(3)(A).
8 17 CFR 240.19b–4(f)(6). Pursuant to Rule 19b–
4(f)(6)(iii) under the Act, the Exchange is required
sroberts on PROD1PC70 with NOTICES
to give the Commission written notice of its intent
to file the proposed rule change, along with a brief
description and text of the proposed rule change,
at least five business days prior to the date of filing
of the proposed rule change, or such shorter time
as designated by the Commission. The Exchange
has satisfied the five-day pre-filing requirement.
VerDate Aug<31>2005 20:08 Dec 19, 2007 Jkt 214001
Commission that such action is
necessary or appropriate in the public
interest, for the protection of investors,
or otherwise in furtherance of the
purposes of the Act.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
Electronic Comments
• Use the Commission’s Internet
comment form (http://www.sec.gov/
rules/sro.shtml); or
• Send an e-mail to rule-
comments@sec.gov. Please include File
Number SR–NYSE–2007–114 on the
subject line.
Paper Comments
• Send paper comments in triplicate
to Nancy M. Morris, Secretary,
Securities and Exchange Commission,
100 F Street, NE., Washington, DC
20549–1090.
All submissions should refer to File
Number SR–NYSE–2007–114. This file
number should be included on the
subject line if e-mail is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (http://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for inspection and copying in
the Commission’s Public Reference
Room, on official business days between Edith Butler, Program Analyst, by
the hours of 10 a.m. and 3 p.m. Copies
of the filing also will be available for
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change; 8(a)(17) of the Small Business Act, (Act)
the Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–NYSE–
2007–114 and should be submitted on
or before January 10, 2008.
PO 00000 Frm 00093 Fmt 4703 Sfmt 4703
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.9
Florence E. Harmon,
Deputy Secretary.
[FR Doc. E7–24728 Filed 12–19–07; 8:45 am]
BILLING CODE 8011–01–P
SMALL BUSINESS ADMINISTRATION
Small Business Size Standards:
Waiver of the Nonmanufacturer Rule
AGENCY: U.S. Small Business
Administration.
ACTION: Notice of Waiver of the
Nonmanufacturer Rule for
Electromedical and Electrotherapeutic
Apparatus Manufacturing.
SUMMARY: The U. S. Small Business
Administration (SBA) is granting a
waiver of the Nonmanufacturer Rule for
Electromedical and Electrotherapeutic
Apparatus Manufacturing, Diagnostic
equipment, MRI (magnetic resonance
imaging) manufacturing; Magnetic
resonance imaging (MRI) medical
diagnostic equipment manufacturing;
Medical ultrasound equipment
manufacturing; MRI (magnetic
resonance imaging) medical diagnostic
equipment manufacturing; Patient
monitoring equipment (e.g., intensive
care coronary care unit) manufacturing;
PET (positron emission equipment
tomography) scanners manufacturing;
and Positron emission tomography
(PET) scanners manufacturing. The
basis for a waiver is that no small
business manufacturers are supplying
this class of product to the Federal
government. The effect of a waiver
would be to allow otherwise qualified
regular dealers to supply the products of
any domestic manufacturer on a Federal
contract set aside for small businesses;
service-disabled veteran-owned small
business or SBA’s 8(a) Business
Development Program.
DATE: This waiver is effective January 4,
2008.
FOR FURTHER INFORMATION CONTACT:
telephone at (202) 619–0422; by FAX at
(202) 481–1788; or by e-mail at
edith.butler@sba.gov.
SUPPLEMENTARY INFORMATION: Section
15 U.S.C. 637(a)(17), requires that
recipients of Federal contracts set aside
for small businesses, service-disabled
veteran-owned small businesses, or
SBA’s 8(a) Business Development
Program provide the product of a small
9 17 CFR 200.30–3(a)(12).
E:\FR\FM\20DEN1.SGM 20DEN1
 72434 Federal Register / Vol. 72, No. 244 / Thursday, December 20, 2007 / Notices
business manufacturer or processor, if
the recipient is other than the actual
manufacturer or processor of the
product. This requirement is commonly
referred to as the Nonmanufacturer
Rule. The SBA regulations imposing
this requirement are found at 13 CFR
121.406(b). Section 8(a)(17)(b)(iv) of the
Act authorizes SBA to waive the
Nonmanufacturer Rule for any ‘‘class of
products’’ for which there are no small
business manufacturers or processors
available to participate in the Federal
market.
As implemented in SBA’s regulations
at 13 CFR 121.1202(c), in order to be
considered available to participate in
the Federal market for a class of
products, a small business manufacturer
must have submitted a proposal for a
contract solicitation or received a
contract from the Federal government
within the last 24 months. The SBA
defines ‘‘class of products’’ based on six
digit coding systems. The first coding
system is the Office of Management and
Budget North American Industry
Classification System (NAICS). The
second is the Product and Service Code
required as a data entry field by the
Federal Procurement Data System.
The SBA received a request on
October 23, 2007 to waive the
Nonmanufacturer Rule for
Electromedical and Electrotherapeutic
Apparatus Manufacturing, Diagnostic
equipment, MRI (magnetic resonance
imaging) manufacturing; Magnetic
resonance imaging (MRI) medical
diagnostic equipment manufacturing;
Medical ultrasound equipment
manufacturing; MRI (magnetic
resonance imaging) medical diagnostic
equipment manufacturing; Patient
monitoring equipment (e.g., intensive
care coronary care unit) manufacturing;
PET (positron emission equipment
tomography) scanners manufacturing;
and Positron emission tomography
(PET) scanners manufacturing. In
response, on November 15, 2007, SBA
published in the Federal Register a
notice of intent to waive the
Nonmanufacturer Rule for
Electromedical and Electrotherapeutic
Apparatus Manufacturing, Diagnostic
equipment, MRI (magnetic resonance
imaging) manufacturing; Magnetic
resonance imaging (MRI) medical
diagnostic equipment manufacturing;
Medical ultrasound equipment
manufacturing; MRI (magnetic
resonance imaging) medical diagnostic
equipment manufacturing; Patient
sroberts on PROD1PC70 with NOTICES
monitoring equipment (e.g, intensive
care coronary care unit) manufacturing;
PET (positron emission equipment
tomography) scanners manufacturing;
and Positron emission tomography
VerDate Aug<31>2005 20:08 Dec 19, 2007 Jkt 214001
(PET) scanners manufacturing. SBA
explained in the notice that it was
soliciting comments and sources of
small business manufacturers of this
class of products.
In response to this notice, a comment
was received from an interested party,
however, no small business
manufacturing sources were discovered.
SBA has determined that there are no
small business manufacturers of this
class of products, and is therefore
granting the waiver of the
Nonmanufacturer Rule for
Electromedical and Electrotherapeutic
Apparatus Manufacturing, Diagnostic
equipment, MRI (magnetic resonance
imaging) manufacturing; Magnetic
resonance imaging (MRI) medical
diagnostic equipment manufacturing;
Medical ultrasound equipment
manufacturing; MRI (magnetic
resonance imaging) medical diagnostic
equipment manufacturing; Patient
monitoring equipment (e.g., intensive
care coronary care unit) manufacturing;
PET (positron emission equipment
tomography) scanners manufacturing;
and Positron emission tomography
(PET) scanners manufacturing, NAICS
334510.
Authority: 15 U.S.C. 637(a)(17).
Dated: December 13, 2007.
Arthur E. Collins, Jr.,
Director, Office of Government Contracting.
[FR Doc. E7–24716 Filed 12–19–07; 8:45 am]
BILLING CODE 8025–01–P
DEPARTMENT OF STATE
[Public Notice 6038]
Culturally Significant Objects Imported
for Exhibition Determinations: ‘‘Color
Chart: Reinventing Color’’
SUMMARY: Notice is hereby given of the
following determinations: Pursuant to
the authority vested in me by the Act of
October 19, 1965 (79 Stat. 985; 22 U.S.C.
2459), Executive Order 12047 of March
27, 1978, the Foreign Affairs Reform and
Restructuring Act of 1998 (112 Stat.
2681, et seq.; 22 U.S.C. 6501 note, et
seq.), Delegation of Authority No. 234 of
October 1, 1999, Delegation of Authority
No. 236 of October 19, 1999, as
amended, and Delegation of Authority
No. 257 of April 15, 2003 [68 FR 19875],
I hereby determine that the objects to be
included in the exhibition ‘‘Color Chart:
Reinventing Color’’, imported from
abroad for temporary exhibition within
the United States, are of cultural
significance. The objects are imported
pursuant to loan agreements with the
foreign owners or custodians. I also
PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\20DEN1.SGM
determine that the exhibition or display
of the exhibit objects at the Museum of
Modern Art, New York, NY, from on or
about March 2, 2008, until on or about
May 12, 2008, and at possible additional
exhibitions or venues yet to be
determined, is in the national interest.
Public Notice of these Determinations is
ordered to be published in the Federal
Register.
FOR FURTHER INFORMATION CONTACT: For
further information, including a list of
the exhibit objects, contact Richard
Lahne, Attorney-Adviser, Office of the
Legal Adviser, U.S. Department of State
(telephone: 202/453–8058). The address
is U.S. Department of State, SA–44, 301
4th Street, SW., Room 700, Washington,
DC 20547–0001.
Dated: December 13, 2007.
C. Miller Crouch,
Principal Deputy Assistant Secretary for
Educational and Cultural Affairs, Department
of State.
[FR Doc. E7–24731 Filed 12–19–07; 8:45 am]
BILLING CODE 4710–05–P
DEPARTMENT OF STATE
[Public Notice 6037]
Culturally Significant Objects Imported
for Exhibition Determinations: ‘‘The
Color of Life’’
SUMMARY: Notice is hereby given of the
following determinations: Pursuant to
the authority vested in me by the Act of
October 19, 1965 (79 Stat. 985; 22 U.S.C.
2459), Executive Order 12047 of March
27, 1978, the Foreign Affairs Reform and
Restructuring Act of 1998 (112 Stat.
2681, et seq.; 22 U.S.C. 6501 note, et
seq.), Delegation of Authority No. 234 of
October 1, 1999, Delegation of Authority
No. 236 of October 19, 1999, as
amended, and Delegation of Authority
No. 257 of April 15, 2003 [68 FR 19875],
I hereby determine that the objects to be
included in the exhibition ‘‘The Color of
Life’’, imported from abroad for
temporary exhibition within the United
States, are of cultural significance. The
objects are imported pursuant to loan
agreements with the foreign owners or
custodians. I also determine that the
exhibition or display of the exhibit
objects at The J. Paul Getty Museum at
the Getty Villa, Malibu, California, from
on or about March 6, 2008, until on or
about June 23, 2008, and at possible
additional exhibitions or venues yet to
be determined, is in the national
interest. Public Notice of these
Determinations is ordered to be
published in the Federal Register.
FOR FURTHER INFORMATION CONTACT: For
further information, including a list of
20DEN1